Clinical Trials in Tennessee

Showing 17801-17820 of 20,239 trials

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

NCT00064064

RATIONALE: Drugs used in chemotherapy such as gemcitabine use different ways to stop tumor cells from dividing so they stop growing or die. 3-AP may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth and may help gemcitabine kill more cancer cells by making them more sensitive to the drug. PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine with 3-AP in treating patients who have metastatic non-small cell lung cancer.

Lung Cancer

Vion PharmaceuticalsStarted Jan 2003

Chicago, Illinois, United States • Minneapolis, Minnesota, United States • Nashville, Tennessee, United States +2 more locations

COMPLETEDPhase 329 miles

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

NCT00516321

The purpose of this study is to assess the ability of eltrombopag to maintain a platelet count sufficient to facilitate initiation of antiviral therapy, to minimise antiviral therapy dose reductions and to avoid permanent discontinuation of antiviral therapy. The clinical benefit of eltrombopag will be measured by the proportion of subjects who are able to achieve a Sustained Virological Response (SVR).

Hepatitis C, Chronic

GlaxoSmithKline687 participantsStarted Oct 2007

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +188 more locations

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

Find Trials by Condition in Tennessee

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

High Dose Trial in COPD

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

Pericoital Oral Contraception With Levonorgestrel